Kelly Young, NP
Nurse Practitioner · Burnsville, MNNPI 1154732360
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $80,730 of the $104,513 with a category attached, or 77.2%. Johnson & Johnson accounts for 90.7% of it on its own, with 2 other manufacturers making up the rest. Among nurse practitioner clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 170 payments — averaging $614.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$95K
- Pharmacyclics LLC, An Abbvie Company$9K
- Janssen Scientific Affairs, LLC$580
What the payments were for
- Consulting fees$1,7202%
- Speaking & faculty fees$80,73077%
- Travel & lodging$19,49219%
- Food & beverage$2,5712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 155 | $94,748 |
| Pharmacyclics LLC, An Abbvie Company | 14 | $9,185 |
| Janssen Scientific Affairs, LLC | 1 | $580 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$104,513 in reported general payments places this provider in the 95th percentile of 3,021 nurse practitioner providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $15,079 |
| Oxycodone Hcl | 38 | $1,186 |
| Tamoxifen Citrate | 14 | $566 |
| Anastrozole | 23 | $519 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $501 |
| Dexamethasone | 29 | $321 |
| Omeprazole | 12 | $238 |
| Ondansetron Hcl | 12 | $181 |
| Prochlorperazine Maleate | 12 | $175 |
| Potassium Chloride | 13 | $175 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $142 |
| Acyclovir | 16 | $134 |
| Lorazepam | 16 | $78 |
| Prednisone | 24 | $69 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Burnsville
- Rebecca SuessBurnsville$110K
- Jill ToliverWoodbury$116K
- Kimberly ThompsonRochester$62K
- Janet WilkinsonMora$57K
- Virginia ClementsonEden Prairie$42K
- Erin PetersonSt Louis Park$37K
- Karen TrutnauEdina$32K
- Margaret VolzMinneapolis$30K
- Joanne HynesCoon Rapids$29K
- Annette HaynesHanska$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.